Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / ALGS - Protagonist Janssen Collaboration And Other News: The Good Bad And Ugly Of Biopharma

ALGS - Protagonist Janssen Collaboration And Other News: The Good Bad And Ugly Of Biopharma

Aligos Therapeutics Inc.
  • Protagonist Therapeutics to develop oral IL-23 receptor antagonists with Janssen.
  • Aligos Therapeutics initiates ALG-000184 proof-of-concept study.
  • Equillium goes ahead with Phase 3 trial for COVID-19 vaccine.

For further details see:

Protagonist Janssen Collaboration, And Other News: The Good, Bad And Ugly Of Biopharma
Stock Information
Company Name: Aligos Therapeutics Inc.
Stock Symbol: ALGS
Market: NASDAQ
Website: aligos.com
Menu
ALGS ALGS Quote ALGS Short ALGS News ALGS Articles ALGS Message Board
Get ALGS Alerts

News, Short Squeeze, Breakout and More Instantly...